Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Boehringer Ingelheim
Medtronic
Harvard Business School
Colorcon

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Patent Applications for duloxetine hydrochloride

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

US Patent Applications for duloxetine hydrochloride

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial Arylpiperazines having activity at the serotonin 1A receptor 2001-01-03 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-04-19
  Start Trial   Start Trial ANTIDEPRESSANT EFFECT OF NOREPINEPHRINE UPTAKE 2 INHIBITORS AND COMBINED MEDICATIONS INCLUDING THEM 2001-03-16 Patented Case 2002-05-24
  Start Trial   Start Trial METHODS OF INHIBITING PLATELET ACTIVATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS 2001-03-12 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2011-05-23
  Start Trial   Start Trial NON-PEPTIDYL VASOPRESSIN V1A ANTAGONISTS 2000-12-08 Patented Case 2003-01-30
  Start Trial   Start Trial Combination of a serotonin reuptake inhibitor and irindalone 2000-12-06 Abandoned -- Failure to Respond to an Office Action 2002-09-19
  Start Trial   Start Trial LONG ACTING ANTIDEPRESSANT MICROPARTICLES 2001-08-30 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2006-12-20
  Start Trial   Start Trial ARYL AND HETEROARYL SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF 2002-03-06 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2015-07-13
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Mallinckrodt
Dow
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.